FindTrial
Sign In

Laboratory Procedure

OTHER4 trials

Sponsors

National Cancer Institute (NCI), University of Southern California, M.D. Anderson Cancer Center, Mayo Clinic

Conditions

Benign Pancreatic NeoplasmColon CarcinomaLiver and Intrahepatic Bile Duct CarcinomaMalignant Pancreatic NeoplasmPancreatic CarcinomaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid LeukemiaRefractory Colorectal Carcinoma

Phase 1

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
CompletedNCT00016016
National Cancer Institute (NCI)Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia +2
Start: 2001-02-28Target: 53Updated: 2013-10-08

Phase 2

Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
Active, not recruitingNCT03844620
M.D. Anderson Cancer CenterRefractory Colorectal Carcinoma, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8 +6
Start: 2019-01-29End: 2026-08-31Updated: 2026-01-09

Unknown Phase

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer
TerminatedNCT03137706
University of Southern CaliforniaColon Carcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Pancreatic Carcinoma
Start: 2016-11-14End: 2020-10-19Updated: 2021-04-05
Answers in Hours A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures
TerminatedNCT05523154
Mayo ClinicBenign Pancreatic Neoplasm, Malignant Pancreatic Neoplasm
Start: 2023-01-19End: 2023-11-27Updated: 2025-02-18

Related Papers

A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D.
Journal of Clinical Oncology2024-06-05
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer
BMJ Open2021-09-0142 citations
A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating cell-free tumor DNA (ctDNA) (TACT-D).
Journal of Clinical Oncology2020-02-012 citations